Sigal Charles Elliott
SEC CIK 1661908 · EDGAR
BoughtSold
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
| 12 | Sigal Charles Elliott | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-28 19:25 | 2026-05-27 | VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +8,000 | 39.8K | +25% | $0 |
| D | 2026-05-22 16:20 | 2026-05-20 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +671 | 1,446 | +87% | $0 |
| D | 2025-06-02 | 2025-05-30 | VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +8,000 | 31.8K | +34% | $0 |
| D | 2025-05-12 | 2025-05-08 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +775 | 775 | New | $0 |
| D | 2024-06-03 | 2024-05-30 | VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +8,000 | 23.8K | +51% | $0 |
| D | 2023-05-24 | 2023-05-22 | VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +6,027 | 15.8K | +62% | $0 |
| I | 2023-03-02 | 2023-03-01 | VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Dir | P - Purchase | $22.73 | +2,500 | 10.0K | +33% | +$56.8K |
| I | 2023-01-09 | 2023-01-05 | VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Dir | P - Purchase | $24.96 | +2,500 | 7,500 | +50% | +$62.4K |
| MI | 2023-01-05 | 2023-01-03+ | VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Dir | P - Purchase | $25.43 | +5,000 | 5,000 | New | +$127.1K |
| D | 2022-05-25 | 2022-05-23 | VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +6,405 | 9,779 | +190% | $0 |
Purchase Sale Sale after option exercise All abbreviations